SEC FORM 4
$61,621.44
Revolution Medicines, Inc. (RVMD)
Sale of 301 shares at $204.7224 per share.
Reporting Person Sandler Alan B. · Officer Title Chief Development Officer · Transaction Code S
Traded Sep 29, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001835966-26-000008 · filed 2026-10-01 · View filing →